ArticleCureus2023

Tumor Necrosis Factor-Alpha (+489 G/A) Polymorphism Can Predict the Response to Adalimumab in Chinese Han Patients With Ankylosing Spondylitis.

Hong-Jin Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.